EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Epigenome in Colorectal Cancer

Antonios N Gargalionis iD, Kostas A Papavassiliou iD, Athanasios G Papavassiliou iD

International Journal of Molecular Sciences · 21.07.2026 · 27 (14) · 6486

DOI: 10.3390/ijms27146486 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.07.2026. Verfasst von Antonios N Gargalionis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Epigenesis, Genetic, Epigenome. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic alterations promote colorectal cancer (CRC) development, plasticity, and drug resistance. Agents have been developed to target epigenetic modifiers; however, they demonstrate limited clinical efficacy. This outcome is the result of the complex interplay within the epigenome, as well as that of the molecular circuits linking these epigenetic vulnerabilities with genetic mutations, oncogenic pathways, and activation of transcription factors. Therefore, current evidence suggests these agents should be assessed in combination with regimens including additional epigenetic drugs, immune checkpoint inhibitors, monoclonal antibodies, and chemotherapeutic drugs. Herein, we highlight recent advances towards epigenome-centered treatment strategies in CRC. We also prioritize potential efforts of epigenetic-associated therapeutic modalities, which should be further developed following integration of respective biomarkers and as tools of therapeutic reprogramming in context-dependent cellular states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEpigenesis, GeneticEpigenomeAnimalsHumansAntineoplastic AgentsDNA MethylationDrug Resistance, NeoplasmGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DNA methylationcolorectal cancerdrug resistanceepigenetic reprogrammingepigenetic therapyhistone modificationsimmunotherapy sensitization

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Antonios N Gargalionis, Kostas A Papavassiliou, Athanasios G Papavassiliou

Zitieren

APA

Gargalionis, A. N., Papavassiliou, K. A., & Papavassiliou, A. G. (2026). Targeting the Epigenome in Colorectal Cancer. International Journal of Molecular Sciences, 27(14), 6486. https://doi.org/10.3390/ijms27146486

Vancouver

Gargalionis AN, Papavassiliou KA, Papavassiliou AG. Targeting the Epigenome in Colorectal Cancer. International Journal of Molecular Sciences. 2026;27(14):6486. doi:10.3390/ijms27146486

BibTeX
@article{Gargalionis2026,
  author = {Gargalionis, Antonios N and Papavassiliou, Kostas A and Papavassiliou, Athanasios G},
  title = {Targeting the Epigenome in Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6486},
  doi = {10.3390/ijms27146486}
}
Kostenlos starten →